Nine more drugmakers agree to Trump pricing policy as administration keeps deal details confidential and experts say Medicaid impact may be negligible.
14 of 17 targeted companies now signed
Read the full story at The Hill
From the December 19, 2025 GovBrief, every story that day in one place.